Cargando…
Multifaceted CK2 in malignant and healthy T cells
Autores principales: | Ribeiro, Sérgio T., Barata, João T., Silva-Santos, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710866/ https://www.ncbi.nlm.nih.gov/pubmed/29207585 http://dx.doi.org/10.18632/oncotarget.21700 |
Ejemplares similares
-
The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia
por: Zhou, Yun, et al.
Publicado: (2020) -
Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support
por: Perera, Yasser, et al.
Publicado: (2020) -
Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor
por: Martins, Leila R., et al.
Publicado: (2013) -
Multifaceted aging and rapamycin
por: Anisimov, Vladimir N.
Publicado: (2013) -
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019)